INT0142_2B: INT0142, figure 2B

INT0142_2BR Documentation

INT0142, figure 2B

Description

Kaplan-Meier digitized data from INT0142, figure 2B (PMID 25349302). A reported sample size of 345 for a primary endpoint of DFS/OS in breast cancer.

Usage

INT0142_2B

Format

A data frame of 337 observations and 3 variables:

time event time (in years)
event DFS event indicator (0: no event, 1: event)
arm treatment arms (tamoxifen, tamoxifen_ofs)

Source

Tevaarwerk AJ, Wang M, Zhao F, et al. Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2014; 32: 3948–58.

Examples

summary(INT0142_2B)

kmplot(INT0142_2B)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.